IQVIA Holdings has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.

IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, ...

IQVIA Market Access Launch Pad is a dynamic and comprehensive suite of tools designed to support pharmaceutical companies in their product launch readiness. It integrates policy structure updates, ...

The Clinical Trials industry is set to achieve significant growth, projecting a value of US$ 99.25 Billion by 2033 from US$ ...

AMT Medical has raised over $40 million to date, including a $25 million Series B round in 2025 led by Bender Analytical Holding B.V. and supported by Invest-NL, the European Innovation Council, and ...

Eli Lilly and Company today announced the U.S. Food and Drug Administration (FDA) approved a label expansion for Zepbound® (tirzepatide) to include the four-dose single-patient use KwikPen® that ...

The deal valued at up to $500 million grants Bio Usawa exclusive, worldwide rights to use and sublicense the DynaShield™ technology across its portfolio and in third-party biologic and vaccine ...

The context-aware, multi-lingual AI agents act like a 24/7 digital FDA reviewer, helping MedTech companies improve ...

Pitney Bowes Inc. ("Pitney Bowes" or the "Company"), a technology-driven products and services company that provides digital shipping solutions, mailing innovation, and financial services to clients ...

The year of the Wood Snake was moderate for China stocks and ETFs, with iShares China Large-Cap ETF FXI gaining about 9.4% ...

The pharma industry has spent much of the last year navigating the Trump administration's tariff threats, but with a seismic Supreme Court ...

While there are shared principles across development programs, Barr noted that the nuances within immunology, ophthalmology, or chronic care studies can determine whether a trial succeeds or fails.